Dr. Reddy’s Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% is an antihistamine eye drop, indicated for the temporary relief of itchy eyes due to pollen, ragweed, grass, animal hair and dander
The new assets expand Biocon Biologics’ already robust oncology portfolio, which now includes 17 cancer therapies
Rajdeep is an accomplished business leader with a strong techno-commercial background in the healthcare and diagnostic sector
Syrma Johari is a globally recognised medical device engineering and manufacturing organisation
Dr. Bandichhor brings nearly two decades of experience from Dr. Reddy's Laboratories
Singh previously served as Head of IT (Development and Manufacturing Services) at Syngene International Limited, Lead of IT Manufacturing at UPL, and AGM at The Hi-Tech Gears
The cancellation underscores the regulator’s strict stance against misleading cosmetic claims
U.S. and Canada transaction supports continued access to RADICAVA for people living with ALS
Production at Biocon Biologics’ own facilities is scheduled to begin once technology transfers and regulatory approvals are finalized
Biocon will be responsible for supplying Semaglutide to Ajanta for exclusive marketing in 23 countries and semi-exclusive marketing in 3 countries across Africa, Middle East and Central Asia
Subscribe To Our Newsletter & Stay Updated
